Shopping Cart 0
Cart Subtotal
USD 0

University of Sydney - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750

Details

Summary

University of Sydney (USYD) is a research institute that provides educational services. The university offers under graduate and post graduate courses. Its services include accommodation and living costs, financial support, disability services, learning assistance, centre for english teaching, library, health and welfare, IT services, careers centre, religious facilities, and child care services, among others. USYD conducts research in the areas of agricultural and veterinary sciences, biological sciences, chemical sciences, commerce, management, tourism and services, creative arts and writing, earth sciences, education, engineering, environmental sciences, and others. The university collaborates with partners in Australia. USYD is headquartered in Darlington, New South Wales, Australia.

University of Sydney-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

University of Sydney, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Sydney, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Sydney, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Sydney, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of Sydney, Medical Devices Deals, 2012 to YTD 2018 9

University of Sydney, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

University of Sydney, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

MediciNova Enters into Agreement with University of Sydney 11

HaemaLogiX Enters into Research Agreement for Immuno-Oncology Agent 12

Tilray Enters into Agreement with New South Wales Government, University of Sydney and Chris O'Brien Lifehouse 13

Licensing Agreements 14

Lin BioScience Enters into Licensing Agreement with University of Sydney 14

University of Sydney-Key Competitors 15

University of Sydney-Key Employees 16

University of Sydney-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Recent Developments 19

Government and Public Interest 19

Sep 18, 2018: Neurodegeneration research boosted by USD 1.25 million gift 19

Sep 10, 2018: New drug discovery initiative focused on innovative therapies 20

Aug 30, 2018: Birth defect predicts testicular cancer, infertility in adulthood 22

Aug 23, 2018: NSW Health grants USD 5 million from the NSW government for cell and gene therapies 23

Aug 15, 2018: Over USD 16m funding for new health and medical research 24

Apr 12, 2018: Scientists unlock path to use cell's nanoparticles as biomarkers 25

Apr 09, 2018: New imaging technique could lower radiation risk from PET scans 27

Feb 06, 2018: New open source drug discovery project aims to develop mycetoma treatment 28

Feb 01, 2018: New research project to help tackle chronic pain 29

Sep 27, 2017: Study Finds "Standard Care" Treatments in Breast Cancer Clinical Trials Not Always Standard 31

Other Significant Developments 32

Aug 15, 2018: Lower radiation doses could have big impact on cancer treatment 32

Aug 10, 2018: New centre uses apps to raise health in Sydney's west 34

Aug 09, 2018: Polypharmacy in the elderly: new project investigates 36

Jul 24, 2018: Software cuts through costly hospital pharmaceutical procurement 38

Appendix 39

Methodology 39

About GlobalData 39

Contact Us 39

Disclaimer 39


List Of Figure

List of Figures

University of Sydney, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Sydney, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Sydney, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Sydney, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Sydney, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Sydney, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

University of Sydney, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Sydney, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of Sydney, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

University of Sydney, Pharmaceuticals & Healthcare, Key Facts, 2016 2

University of Sydney, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Sydney, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Sydney, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Sydney, Deals By Therapy Area, 2012 to YTD 2018 8

University of Sydney, Medical Devices Deals, 2012 to YTD 2018 9

University of Sydney, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

MediciNova Enters into Agreement with University of Sydney 11

HaemaLogiX Enters into Research Agreement for Immuno-Oncology Agent 12

Tilray Enters into Agreement with New South Wales Government, University of Sydney and Chris O'Brien Lifehouse 13

Lin BioScience Enters into Licensing Agreement with University of Sydney 14

University of Sydney, Key Competitors 15

University of Sydney, Key Employees 16

University of Sydney, Subsidiaries 17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

University of Sydney, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

University of Sydney (USYD) is a research institute that provides educational services. The university offers under graduate and post graduate courses. Its services include accommodation and living costs, financial support, disability services, learning assistance, centre for english teaching, library, health and welfare, IT services, careers centre, religious facilities, and child care services, among others. USYD conducts research in the areas of agricultural and veterinary sciences, biological sciences, chemical sciences, commerce, management, tourism and services, creative arts and writing, earth sciences, education, engineering, environmental sciences, and others. The university collaborates with partners in Australia. USYD is headquartered in Darlington, New South Wales, Australia.

University of Sydney-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

University of Sydney, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Sydney, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Sydney, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Sydney, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of Sydney, Medical Devices Deals, 2012 to YTD 2018 9

University of Sydney, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

University of Sydney, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

MediciNova Enters into Agreement with University of Sydney 11

HaemaLogiX Enters into Research Agreement for Immuno-Oncology Agent 12

Tilray Enters into Agreement with New South Wales Government, University of Sydney and Chris O'Brien Lifehouse 13

Licensing Agreements 14

Lin BioScience Enters into Licensing Agreement with University of Sydney 14

University of Sydney-Key Competitors 15

University of Sydney-Key Employees 16

University of Sydney-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Recent Developments 19

Government and Public Interest 19

Sep 18, 2018: Neurodegeneration research boosted by USD 1.25 million gift 19

Sep 10, 2018: New drug discovery initiative focused on innovative therapies 20

Aug 30, 2018: Birth defect predicts testicular cancer, infertility in adulthood 22

Aug 23, 2018: NSW Health grants USD 5 million from the NSW government for cell and gene therapies 23

Aug 15, 2018: Over USD 16m funding for new health and medical research 24

Apr 12, 2018: Scientists unlock path to use cell's nanoparticles as biomarkers 25

Apr 09, 2018: New imaging technique could lower radiation risk from PET scans 27

Feb 06, 2018: New open source drug discovery project aims to develop mycetoma treatment 28

Feb 01, 2018: New research project to help tackle chronic pain 29

Sep 27, 2017: Study Finds "Standard Care" Treatments in Breast Cancer Clinical Trials Not Always Standard 31

Other Significant Developments 32

Aug 15, 2018: Lower radiation doses could have big impact on cancer treatment 32

Aug 10, 2018: New centre uses apps to raise health in Sydney's west 34

Aug 09, 2018: Polypharmacy in the elderly: new project investigates 36

Jul 24, 2018: Software cuts through costly hospital pharmaceutical procurement 38

Appendix 39

Methodology 39

About GlobalData 39

Contact Us 39

Disclaimer 39


List Of Figure

List of Figures

University of Sydney, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Sydney, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Sydney, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Sydney, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Sydney, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Sydney, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

University of Sydney, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Sydney, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of Sydney, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

University of Sydney, Pharmaceuticals & Healthcare, Key Facts, 2016 2

University of Sydney, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Sydney, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Sydney, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Sydney, Deals By Therapy Area, 2012 to YTD 2018 8

University of Sydney, Medical Devices Deals, 2012 to YTD 2018 9

University of Sydney, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

MediciNova Enters into Agreement with University of Sydney 11

HaemaLogiX Enters into Research Agreement for Immuno-Oncology Agent 12

Tilray Enters into Agreement with New South Wales Government, University of Sydney and Chris O'Brien Lifehouse 13

Lin BioScience Enters into Licensing Agreement with University of Sydney 14

University of Sydney, Key Competitors 15

University of Sydney, Key Employees 16

University of Sydney, Subsidiaries 17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

University of Sydney, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.